Steven Cohen Apellis Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

$39.3 Billion
Q1 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 267,823 shares of APLS stock, worth $10.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

267,823

Holding current value

$10.3 Million

% of portfolio

0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $14.8 Million - $19.4 Million	267,823 New	267,823 $15.7 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $49.1 Million - $59.8 Million	-640,363 Reduced 34.07%	1,239,361 $113 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $87.6 Million - $126 Million	1,879,724 New	1,879,724 $124 Million
Q2 2021 Aug 16, 2021	SELL	$40.9 - $64.9 $10.2 Million - $16.2 Million	-250,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $9.25 Million - $13 Million	226,600 Added 968.38%	250,000 $10.7 Million

Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $13 Million - $24.2 Million	-423,536 Reduced 94.76%	23,400 $1.34 Million
Q3 2020 Nov 16, 2020	BUY	$25.89 - $33.65 $6.18 Million - $8.04 Million	238,833 Added 114.77%	446,936 $13.5 Million
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $2.78 Million - $4.32 Million	-112,198 Reduced 35.03%	208,103 $6.8 Million
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $5.74 Million - $14.2 Million	320,301 New	320,301 $8.58 Million
Q3 2019 Nov 15, 2019	SELL	$24.09 - $32.18 $9.66 Million - $12.9 Million	-401,104 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.0 - $25.34 $1.21 Million - $1.71 Million	67,475 Added 20.22%	401,104 $10.2 Million
Q1 2019 May 15, 2019	BUY	$12.81 - $19.82 $2.85 Million - $4.41 Million	222,613 Added 200.52%	333,629 $6.51 Million
Q4 2018 Feb 14, 2019	BUY	$11.47 - $18.71 $1.27 Million - $2.08 Million	111,016 New	111,016 $1.46 Million

Others Institutions Holding APLS

# of Institutions

337

Shares Held

111M

Call Options Held

1.26M

Put Options Held

1.14M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $4.21B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account